Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Antimicrobial and antitumor activity of xenomin compounds described

Nov. 30, 1998

Viral and nonviral serine protease inhibitors developed at Emory University

Nov. 27, 1998

Design, synthesis and antiviral activity of A-5021 discussed this week in Kyoto

Nov. 26, 1998

Preliminary results announced for pleconaril pediatric study; other trials in progress

Nov. 26, 1998

Herpesvirus protease inhibitors developed at SmithKline Beecham

Nov. 25, 1998

Pentose receives SBIR grant to support Inactine development

Nov. 25, 1998

Bayer claims broad-spectrum oxazolidinones

Nov. 23, 1998

Ajinomoto identifies mechanism of anti-HSV and anti-VZV actions of A-5021

Nov. 23, 1998

Erythromycin derivatives with high activity against sensitive and resistant microorganisms

Nov. 20, 1998

Picornavirus protease inhibitors from Agouron especially useful for rhinovirus infections

Nov. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...